Nanoco in best position in its 20-year history

Nanoco has reported better interim revenues and reduced pre-tax losses for the six month period to January 31, 2023, today.

The University of Manchester spin-out, which has relocated to Runcorn, develops materials used in the manufacture of monitors and TV screens and technologies for medical imaging and the early diagnosis of cancer.

Revenues of £1.562m, were up from £1.099m the previous year, while pre-tax losses reduced slightly, from £2.347m a year ago, to £2.334m.

The business benefited from its successful IP litigation case against South Korean electronics giant Samsung in February which will pay Nanoco $150m.

Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, vertical farming, solar energy and bio-imaging.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical